| 期刊論文| 1. | Laruelle, M.、Abi-Dargham, A.、Gil, R.、Kegeles, L.、Innis, R.(1999)。Increased dopamine transmission in schizophrenia: relationship to illness phases。Biol Psychiatry，46，56-72。   | | 2. | Abi-Dargham, A.、Gil, R.、Krystal, J.、Baldwin, R. M.、Seibyl, J. P.、Bowers, M.、Laruelle, M.(1998)。Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort。American Journal of Psychiatry，155，761-767。 | | 3. | Laruelle, M.(2000)。Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review。J Cereb Blood Flow Metab，20，423-451。 | | 4. | Hsiao, M. C.、Lin, K. J.、Liu, C. Y.、Tzen, K. Y.、Yen, T. C.(2003)。Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1。Schizophr Res，65，39-46。 | | 5. | Okubo, Y.、Suhara, T.、Suzuki, K.(1997)。Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET。Nature，385，634-636。 | | 6. | Wagner, H. N.、Bums, H. D.、Dannals, R. F.(1983)。Imaging dopamine receptors in the human brain by positron tomography。Science，221，1264-1266。 | | 7. | Sedvall, G.、Farde, L.、Persson, A.、Wiesel, F. A.(1986)。Imaging of neurotransmitter receptors in the living hum an brain。Arch Gen Psychiatry，43，995-1005。 | | 8. | Wong, D. F.、Wagner, H. N.、Tune, L. E.(1986)。Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics。Science，234，1558-1563。 | | 9. | Andreasen, N. C.、Carson, R.、Diksic, M.(1988)。Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum。Schizophr Bull，14，471-484。 | | 10. | Seeman, P.、Guan, H. C.、Niznik, H. B.(1989)。Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain。Synapse，3，96-97。 | | 11. | Burstein, E. S.、Spalding, T. A.、Hill-Eubanks, D.、Brann, M. R.(1995)。Structure-function of muscarinic receptor coupling to G proteins. Random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins。J Biol Chem，270，3141-3146。 | | 12. | Chou, Y. H.、Karlsson, P.、Halldin, G.、Olsson, H.、Farde, L.(1999)。A PET study of D(l)4ike dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain。Psychopharmacology，146，220-227。 | | 13. | Surti, S.、Karp, J. S.、Kinahan, P. E.(2004)。PET instrumentation。Radiol Clin North Am，42，1003-1016。 | | 14. | Daube-Witherspoon, M. E.、Zubal, I. G.、Karp, J. S.(2003)。Developments in instrumentation for emissioncomputed tomography。SemNucl Med，33，28-41。 | | 15. | Farde, L.(1996)。The advantage of using positron emission tomography in drug research。Trends Neurosci，19，211-214。 | | 16. | Peters, A. M.(1998)。Fundamentals of tracer kinetics for radiologists。Brit J Radiol，71，1116-1129。 | | 17. | Alavi, A.、Lakhani, P.、Mavi, A.、Kung, J. W.、Zhuang, H.(2004)。PET: a revolution in medical imaging。Radiol Clin North Am，42，983-1001。 | | 18. | Farde, L.、Eriksson, L.、Blomquist, G.、Halldin, C.(1989)。Kinetic analysis of central [llC]raclopride binding to D2-dopamine receptors studied by PET-a comparison to the equilibrium analysis。J Cereb Blood Flow Metab，9，696-708。 | | 19. | Wong, D. F.、Gjedde, A.、Wagner, H. N.(1986)。Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands。J Cereb Blood Flow Metab，6，137-146。 | | 20. | Mintun, M. A.、Raichle, M. E.、Kilboum, M. R.、Wooten, G. F.、Welch, M. J.(1984)。A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography。Ann Neurol，15，217-227。 | | 21. | Ito, H.、Hietala, J.、Blomqvist, G.、Halldin, C.、Farde, L.(1998)。Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [llC]raclopride binding。J Cereb Blood Flow Metab，18，941-950。 | | 22. | Hall, H.、Farde, L.、Sedvall, G.(1988)。Human dopamine receptor subtypes-in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride。JNeur Transm Gen Sec，73，7-21。 | | 23. | Farde, L.、Halldin, C.、Stone-Elander, S.、Sedvall, G.(1987)。PET analysis of human dopamine receptor sub-types using 11C-SCH 23390 and llC-raclopride。Psychopharmacology，92，278-284。 | | 24. | De Lean, A.、Stadel, J. M.、Lefkowitz, R. J.(1980)。A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor。J Biol Chem，255，7108-7117。 | | 25. | Farde, L.、Wiesel, F. A.、Nilsson, L.、Sedvall, G.(1989)。The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics。Psychopharmacol Series，7，32-39。 | | 26. | Laruelle, M.(1998)。Imaging dopamine transmission in schizophrenia: A review and meta-analysis。Quarterly JNucl Med，42，211-221。 | | 27. | Olsson, H.、Halldin, C.、Swahn, C. G.、Farde, L.(1999)。Quantification of (llC)FLB 457 binding to extrastriatal dopamine receptors in the human brain。J Cereb Blood Flow Metab，19，1164-1173。 | | 28. | Talvik, M.、Nordstrom, A. L.、Olsson, H.(2003)。Decreased thalamic D2/D3 receptor binding in dragnaive patients with schizoplirenid。Int J Neuropsychop-harmacol，6，361-370。 | | 29. | Suhara, T.、Okubo, Y.、Yasuno, F.(2002)。Decreased dopamine D2 receptor binding in the anterior cingu- late cortex in schizophrenia。Arch Gen Psychiatry，59，25-30。 | | 30. | Abi-Dargham, A.、Mawlawi, O.、Lombardo, I.(2002)。Prefrontal dopamine D1 receptors and working memory in schizophrenia。J Neurosci，22，3708-3719。 | | 31. | Karlsson, P.、Farde, L.、Halldin, C.、Sedvall, G.(2002)。PET study of D(l) dopamine receptor binding in neuroleptic-naive patients with schizophrenia。Am J Psychiatry，159，761-767。 | | 32. | Sjoholm, H.、Bratlid, T.、Sundsfjord, J.(2004)。1231-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia。Psychopharmacology，173，27-31。 | | 33. | Laakso, A.、Vilkman, H.、Alakare, B.(2000)。Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography。Am J Psychiatry，157，269-271。 | | 34. | Okubo, Y.、Suhara, T.、Suzuki, K.(2000)。Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography。Life Sci，66，2455-2464。 | | 35. | Farde, L.、Nordstrom, A.-L.、Wiesel, F.-A.、Pauli, S.、Halldin, C.、Sedvall, G.(1992)。Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects。Arch Gen Psychiatry，49，538-544。 | | 36. | Nordstrom, A. L.、Farde, L.、Nyberg, S.、Karlsson, P.、Halldin, C.、Sedvall, G.(1995)。5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients。Am J Psychiatry，152，1444-1449。 | | 37. | Stephenson, C. M. E.、Bigliani, V.、Jones, H. M.(2000)。Striatal and extra-striatal D2/D3 dopamine receptor occupancy by quetiapine in vivo: (123I)-epide-pride single photon emission tomography (SPET) study。Brit J Psychiatry，177，408-415。 | | 38. | Kapur, S.、Remington, G.、Zipursky, R. B.、Wilson, A. A.、Houle, S.(1995)。The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study。Life Sci，57，103-107。 | | 39. | Kopecek, M.、Hoschl, C.、Hajek, T.(2002)。Regional selectivity of novel antipsychotics。Brit J Psychiatry，181，254-255。 | | 40. | Pilowsky, L. S.、Mulligan, R. S.、Acton, P. D.、Ell, P. J.、Costa, D. C.、Kerwin, R. W.(1997)。Limbic selectivity of clozapine。Lancet，350，490-491。 | | 41. | Talvik, M.、Nordstrom, A. L.、Nyberg, S.、Olsson, H.、Halldin, C.、Farde, L.(2001)。No support for regional selectivity in clozapine-treated patients: A PET study with (llC)raclopride and (llC)FLB 457。Am J Psychiatry，158，926-930。 | | 42. | Kessler, R. M.、Meltzer, H. Y.(2002)。Regional selectivity in clozapine treatment。Am J Psychiatry，159，1064-1065。 | | 43. | Bressan, R. A.、Erlandsson, K.、Jones, H. M.(2002)。Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients。Am J Psychiatry，160，1413-1420。 | | 44. | Xiberas, X.、Martinot, J. L.、Mallet, L.(2001)。In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia。J Clin Psychopharmacol，21，207-214。 | | 45. | Chou, Y. H.、Halldin, C.、Farde, L.(2006)。Clozapine preferentially binds to cortical Dl-like dopamine receptors in primate brain: a PET study。Psychopharmacology，185(1)，29-35。 | | 46. | Arvanitis, L. A.、Miller, B. G.(1998)。Multiple fixed doses of "Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo: The Seroquel Trial 13 Study Group。Biol Psychiatry，42，233-243。 | | 47. | Hagberg, G.、GefVert, O.、Bergstrom, M.(1998)。N-[11C]methylspiperone PET, in contrast to [11C] raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic。Psychiatry Res，82，147-160。 | | 48. | Cheer, S. M.、Wagstaff, A. J.(2004)。Quetiapine: A review of its use in the management of schizophrenia。CNS Drugs，18，173-199。 | | 49. | Gefvert, O.、Bergstrom, M.、Langstrom, B.、Lundberg, T.、Lindstrom, L.、Yates, R.(1998)。Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia。Psychopharmacology，135，119-126。 | | 50. | Yokoi, F.、Grunder, G.、Biziere, K.(2002)。Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): A study using positron emission tomography and (11C) raclopride。Neuropsychopharmacology，27，248-259。 | | 51. | Koepp, M. J.、Gunn, R. N.、Lawrence, A. D.(1998)。Evidence for striatal dopamine release during a video game。Nature，393，266-268。 | | 52. | Luurtsema, G.、de Lange, E. C.、Lammertsma, A. A.、Franssen, E. J.(2004)。Transport across the blood-brain barrier: stereoselectivity and PET-tracers。Mol Imag Biol，6，306-318。 | | 53. | Halldin, C.、Erixon-Lindroth, N.、Pauli, S.(1998)。[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain。Eur J Nucl Med Mol Imag，30，1220-1230。 | | 54. | Lundberg, J.、Odano, I.、Olsson, H.、Halldin, C.、Farde, L.(2005)。Quantification of 11C-MADAM binding to the serotonin transporter in the human brain。J Nucl Med，46，1505-1515。 | | 55. | Chouinard, G.、Jones, B.、Remington, G.(1993)。A Canadian Multicenter Placebo-controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients。Journal of Clinical Psychopharmacology，13(1)，25-40。 | | 56. | Van Dyck, C. H.、Abi-Dargham, A.、Laruelle, M.、Gil, R.、D'Souza, C. D.、Erdos, J.、Baldwin, R. M.(1996)。Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects。Proceedings of the National Academy of Sciences of the United States of America，93，9235-9240。 | | 57. | Saunders, R.、Su, T. P.、Breier, A.(1997)。Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method。Proceedings of the National Academy of Sciences of the United States of America，94，2569-2574。 | | 58. | Kapur, S.、Zipursky, R. B.、Remington, G.(1999)。Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia。The American Journal of Psychiatry，156，286-293。 | | 59. | Kapur, S.、Zipursky, R.、Jones, C.、Shammi, C. S.、Remington, G.、Seeman, P.(2000)。A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect with Only Transiently High Dopamine D2 Receptor Occupancy。Archives of General Psychiatry，57(6)，553-559。 | | 60. | Farde, L.、Hall, H.、Ehrin, E.、Sedvall, G.(1986)。Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET。Science，231，258-261。 | 圖書| 1. | Kenakin, T.(1997)。Molecular pharmacology: a short course。North Carolina：Blackwell。 | | 2. | Stahl, S. M.(1996)。Essential Psychopharmacology: Neuroscientific Basis and Practical Applications。New York：Cambridge。 | |
| |